Medically reviewed by Jamin Brahmbhatt, MD The treatment of metastatic castration-resistant prostate cancer (mCRPC) involves ...

During the transition to menopause, your ovaries produce less estrogen and progesterone. This can lead to symptoms such as ...

When treating patients with hormone-receptor positive, HER2-negative metastatic breast cancer, mutations necessitate the ...

Kevin P. Martin Jr. was shocked to learn he had stage 4 prostate cancer at 61. The endurance athlete has vowed to stay active ...

Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

Former Bachelorette star Katie Thurston is sharing a major update on her cancer journey after having to put her treatments on ...

Katie Thurston, who became a fan favourite on season 17 of ‘The Bachelorette’, has revealed she is facing the biggest battle ...

The Hormone Replacement Therapy Market is valued at USD 16.91 Billion in 2024 and is expected to reach USD 33.84 Billion by ...

The phase 2a LEGION-100 trial seeks to evaluate the safety and effectiveness of the SYNC-T/SV-102 combination therapy for treating metastatic castration-resistant prostate cancer (mCRPC) and to ...

Breast cancer subtyping is essential for determining appropriate treatment strategies, as each molecular category, luminal A, ...

The incidence of interval breast cancer has increased over a 30-year period while the proportion has remained steady.